Case Report: Successful liver transplantation after achieving complete clinical remission of advanced HCC with Atezolizumab plus Bevacizumab combination therapy

BACKGROUND: Atezolizumab plus Bevacizumab combination therapy has recently emerged as the new standard of care for unresectable HCC. Significant tumor burden reduction can be observed under that treatment, raising the question of liver transplantation (LT). The safety of another immune checkpoint in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chouik, Yasmina, Erard, Domitille, Demian, Hassan, Schulz, Thomas, Mazard, Tessa, Hartig-Lavie, Kerstin, Antonini, Teresa, Mabrut, Jean-Yves, Mohkam, Kayvan, Rode, Agnès, Merle, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291060/
https://www.ncbi.nlm.nih.gov/pubmed/37377975
http://dx.doi.org/10.3389/fimmu.2023.1205997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291060/
https://www.ncbi.nlm.nih.gov/pubmed/37377975
http://dx.doi.org/10.3389/fimmu.2023.1205997

Ejemplares similares